These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32189965)

  • 21. A simple self-assembly nanomicelle based on brain tumor-targeting peptide-mediated siRNA delivery for glioma immunotherapy via intranasal administration.
    Tang L; Zhang R; Wang Y; Zhang X; Yang Y; Zhao B; Yang L
    Acta Biomater; 2023 Jan; 155():521-537. PubMed ID: 36384220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temozolomide-Induced Changes in Gut Microbial Composition in a Mouse Model of Brain Glioma.
    Li XC; Wu BS; Jiang Y; Li J; Wang ZF; Ma C; Li YR; Yao J; Jin XQ; Li ZQ
    Drug Des Devel Ther; 2021; 15():1641-1652. PubMed ID: 33907383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of temozolomide on immune response during malignant glioma chemotherapy.
    Sengupta S; Marrinan J; Frishman C; Sampath P
    Clin Dev Immunol; 2012; 2012():831090. PubMed ID: 23133490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mustard-inspired delivery shuttle for enhanced blood-brain barrier penetration and effective drug delivery in glioma therapy.
    Wang N; Sun P; Lv M; Tong G; Jin X; Zhu X
    Biomater Sci; 2017 May; 5(5):1041-1050. PubMed ID: 28378865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunological factors relating to the antitumor effect of temozolomide chemoimmunotherapy in a murine glioma model.
    Kim TG; Kim CH; Park JS; Park SD; Kim CK; Chung DS; Hong YK
    Clin Vaccine Immunol; 2010 Jan; 17(1):143-53. PubMed ID: 19889936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic antitumor effect with indoleamine 2,3-dioxygenase inhibition and temozolomide in a murine glioma model.
    Hanihara M; Kawataki T; Oh-Oka K; Mitsuka K; Nakao A; Kinouchi H
    J Neurosurg; 2016 Jun; 124(6):1594-601. PubMed ID: 26636389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Developing a clinically relevant radiosensitizer for temozolomide-resistant gliomas.
    Minea RO; Duc TC; Swenson SD; Cho HY; Huang M; Hartman H; Hofman FM; Schönthal AH; Chen TC
    PLoS One; 2020; 15(9):e0238238. PubMed ID: 32881880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ATRX/EZH2 complex epigenetically regulates FADD/PARP1 axis, contributing to TMZ resistance in glioma.
    Han B; Meng X; Wu P; Li Z; Li S; Zhang Y; Zha C; Ye Q; Jiang C; Cai J; Jiang T
    Theranostics; 2020; 10(7):3351-3365. PubMed ID: 32194873
    [No Abstract]   [Full Text] [Related]  

  • 29. Local delivery of slow-releasing temozolomide microspheres inhibits intracranial xenograft glioma growth.
    Dong J; Zhou G; Tang D; Chen Y; Cui B; Dai X; Zhang J; Lan Q; Huang Q
    J Cancer Res Clin Oncol; 2012 Dec; 138(12):2079-84. PubMed ID: 22825126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists.
    Liu Z; Jiang X; Gao L; Liu X; Li J; Huang X; Zeng T
    World Neurosurg; 2019 Aug; 128():e468-e477. PubMed ID: 31048057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood-brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy.
    Galstyan A; Markman JL; Shatalova ES; Chiechi A; Korman AJ; Patil R; Klymyshyn D; Tourtellotte WG; Israel LL; Braubach O; Ljubimov VA; Mashouf LA; Ramesh A; Grodzinski ZB; Penichet ML; Black KL; Holler E; Sun T; Ding H; Ljubimov AV; Ljubimova JY
    Nat Commun; 2019 Aug; 10(1):3850. PubMed ID: 31462642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CDK4/6 inhibition suppresses tumour growth and enhances the effect of temozolomide in glioma cells.
    Cao Y; Li X; Kong S; Shang S; Qi Y
    J Cell Mol Med; 2020 May; 24(9):5135-5145. PubMed ID: 32277580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new anti-glioma therapy, AG119: pre-clinical assessment in a mouse GL261 glioma model.
    Towner RA; Ihnat M; Saunders D; Bastian A; Smith N; Pavana RK; Gangjee A
    BMC Cancer; 2015 Jul; 15():522. PubMed ID: 26177924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The PYK2 inhibitor PF-562271 enhances the effect of temozolomide on tumor growth in a C57Bl/6-Gl261 mouse glioma model.
    Ortiz-Rivera J; Nuñez R; Kucheryavykh Y; Kucheryavykh L
    J Neurooncol; 2023 Feb; 161(3):593-604. PubMed ID: 36790653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD147 confers temozolomide resistance of glioma cells via the regulation of β-TrCP/Nrf2 pathway.
    Bu X; Qu X; Guo K; Meng X; Yang X; Huang Q; Dou W; Feng L; Wei X; Gao J; Sun W; Chao M; Han L; Hu Y; Shen L; Zhang J; Wang L
    Int J Biol Sci; 2021; 17(12):3013-3023. PubMed ID: 34421346
    [No Abstract]   [Full Text] [Related]  

  • 36. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.
    Bi Y; Li H; Yi D; Sun Y; Bai Y; Zhong S; Song Y; Zhao G; Chen Y
    Mol Pharm; 2018 Nov; 15(11):4912-4925. PubMed ID: 30336060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Folic acid-decorated astrocytes-derived exosomes enhanced the effect of temozolomide against glioma.
    Liu HM; Zhang Y
    Kaohsiung J Med Sci; 2024 May; 40(5):435-444. PubMed ID: 38482902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma.
    Xin H; Jiang X; Gu J; Sha X; Chen L; Law K; Chen Y; Wang X; Jiang Y; Fang X
    Biomaterials; 2011 Jun; 32(18):4293-305. PubMed ID: 21427009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles.
    Ruan S; Yuan M; Zhang L; Hu G; Chen J; Cun X; Zhang Q; Yang Y; He Q; Gao H
    Biomaterials; 2015 Jan; 37():425-35. PubMed ID: 25453970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The temozolomide derivative 2T-P400 inhibits glioma growth via administration route of intravenous injection.
    Li R; Tang D; Zhang J; Wu J; Wang L; Dong J
    J Neurooncol; 2014 Jan; 116(1):25-30. PubMed ID: 24065569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.